We are live on ! Find out more
BLU

BELLUS Health Inc.
BLU

Delisted

BLU was delisted on the 28th of June, 2023.

Back to rankings

89 hedge funds and large institutions have $711M invested in BELLUS Health Inc. in 2021 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 20 increasing their positions, 19 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 7

200% more funds holding in top 10

Funds holding in top 10: 2 → 6 (+4)

144% more capital invested

Capital invested by funds: $291M → $711M (+$420M)

62% more funds holding

Funds holding: 55 → 89 (+34)

5% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 19

26% less call options, than puts

Call options by funds: $11.6M | Put options by funds: $15.6M

Holders
89
Holders Change
+34
Holders Change %
+61.82%
% of All Funds
1.37%
Holding in Top 10
6
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+200%
% of All Funds
0.09%
New
42
Increased
20
Reduced
19
Closed
7
Calls
$11.6M
Puts
$15.6M
Net Calls
-$3.99M
Net Calls Change
-$8.65M

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$67.9M
2
PA
Perceptive Advisors
New York
+$50.7M
3
AG
Artal Group
Luxembourg
+$21.6M
4
CC
Commodore Capital
New York
+$20.7M
5
DM
Deerfield Management
New York
+$16.3M

Top Sellers

Rank Fund Capital Flow
1
ACP
Acuta Capital Partners
California
-$9.84M
2
SAM
Sectoral Asset Management
Quebec, Canada
-$8.08M
3
APM
Avidity Partners Management
Texas
-$7.74M
4
O
OrbiMed
New York
-$6.64M
5
IC
Ikarian Capital
Texas
-$4.61M
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
76
Osaic Holdings
Arizona
$19K -$1.99K -300 -11%
Citigroup
77
Citigroup
New York
$19K +$15.9K +2,397 New
Optiver Holding
78
Optiver Holding
Netherlands
$18K – – –
PCH
79
Polar Capital Holdings
United Kingdom
$16.1K -$4.14M -623,109 -24%
TRCT
80
Tower Research Capital (TRC)
New York
$11K +$8.91K +1,342 New
ACM
81
Aquatic Capital Management
Illinois
$8K +$6.64K +1,000 New
UB
82
UMB Bank
Missouri
$3K +$2.65K +400 New
TWA
83
TCI Wealth Advisors
Arizona
$2K – – –
Daiwa Securities Group
84
Daiwa Securities Group
Japan
$2K +$1.52K +229 New
GCM
85
Gables Capital Management
Florida
$1K – – –
LC
86
Lindbrook Capital
California
$1K – – –
TWC
87
TD Waterhouse Canada
Ontario, Canada
$361 +$252 +38 New
FM
88
Frazier Management
Washington
– -$2.65M -433,247 Closed
ECM
89
Endurant Capital Management
California
– -$2.39M -389,833 Closed
Point72 Asset Management
90
Point72 Asset Management
Connecticut
– -$763K -124,278 Closed
VF
91
Virtu Financial
New York
– -$469K -76,464 Closed
BFM
92
Boothbay Fund Management
New York
– -$462K -75,225 Closed
CM
93
Caption Management
Oklahoma
– -$219K -33,000 Closed
RE
94
RBC Europe
United Kingdom
– -$25.8K -4,200 Closed
Toronto Dominion Bank
95
Toronto Dominion Bank
Ontario, Canada
– -$153 -23 -70%
1 2 3
4

BLU Hedge Fund Activity: Q4 2021 in Review

89 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q4 2021, worth a combined $711M — up 144% from $291M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new BLU positions and 7 closed out — a net gain of 35 holders — while 20 added to existing stakes and 19 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $67.9M. The largest seller was Acuta Capital Partners, cutting an estimated $9.84M.

  • 89 institutional investors held BELLUS Health Inc. (BLU) as of Q4 2021, up from 55 in Q3 2021.
  • Funds reported $711M of BELLUS Health Inc. stock for Q4 2021, up 144% quarter-over-quarter.
  • 42 funds opened new BELLUS Health Inc. positions in Q4 2021 and 7 closed out, a net change of +35 holders.
  • The largest BELLUS Health Inc. buyer in Q4 2021 was RA Capital Management, an estimated $67.9M added.
  • The largest BELLUS Health Inc. seller in Q4 2021 was Acuta Capital Partners, an estimated $9.84M sold.

Based on aggregated 13F filings for Q4 2021.